MAPT and type 2 diabetes mellitus: Here, we report that PLB2TAU mice with low levels of neuronal human mutated tau expression [17] display the onset of T2D-like symptoms (impaired insulin tolerance) at 3 months of age, gradually progressing with age, where elevated blood insulin levels and impaired glucose handling as well as insulin resistance can be observed at 8 months of age.